Liebner, Stefan https://orcid.org/0000-0002-4656-2258
Dijkhuizen, Rick M.
Reiss, Yvonne
Plate, Karl H.
Agalliu, Dritan
Constantin, Gabriela
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LI911/5-1, INST 35/869, SFB/TR23 C1, SFB/TR23 C1, ECCPS, ECCPS)
H2020 Marie Skłodowska-Curie Actions (H2020-MSCA-ITN-2015)
Netherlands Organization for Scientific Research (016.130.662)
EU Joint Programme–Neurodegenerative Disease Research (733051067)
Hartstichting (CVON2015-01)
Deutsche Forschungsgemeinschaft (ECCPS)
German Cancer Consortium (DKTK, DKTK)
DZHK (Column B)
National Institutes of Health ((#R01 HL116995, #R56 MH109987, #R01 MH112849)
National Multiple Sclerosis Society (NMSS #RG4673A1/1)
Leducq Foundation
European Research Council (695714, 693606)
American Drug Discovery Foundation
Article History
Received: 2 November 2017
Revised: 24 January 2018
Accepted: 30 January 2018
First Online: 6 February 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.